1 / 1

Clinical Features of NOD/SCID Mice Injected with HT-SC or TOLEDO-SC Cells via Tail Vein

This study examines the clinical features and survival times of NOD/SCID mice injected with either HT-SC or TOLEDO-SC cells through the tail vein. The data shows that animals experienced a significant decrease in body weight (15-20%) and immobility, leading to their sacrifice on day 29. The results highlight the impact of cell injection on the health and survival of NOD/SCID mice, emphasizing the need for careful monitoring and assessment in future research.

abner
Télécharger la présentation

Clinical Features of NOD/SCID Mice Injected with HT-SC or TOLEDO-SC Cells via Tail Vein

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Online Resource 1. Clinical features of the NOD/SCID mice injected with HT-SC or TOLEDO-SC cells via the tail vein. • Survival time values represent Mean ± SD. * Animals had to be sacrificed on day 29 because all of them showed a sudden • and simultaneous 15-20% reduction of body weight associated with immobility. Bosch et al. Online Resource 1

More Related